What We're Reading: Page 341
Industry reads hand-picked by our editors
Mar 21, 2016
-
Inc.com
What This Guy Learned From Doing Martin Shkreli's PR
-
STAT
Avoiding ‘teapot tempest,’ Clinton campaign distances itself from Theranos
-
Washington Post
A window into one of the most baffling things about drug prices
-
Tech Crunch
YC-backed Perlstein Lab continues their rare disease drug discovery
Mar 18, 2016
Mar 17, 2016
-
ProPublica
Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds
-
Forbes
Five Lessons Big Pharma Should Learn From Valeant's Collapse
-
FierceBiotech
GSK adds Miltenyi Biotec to its oncology shopping CAR-T as Witty checks out
-
STAT
1 in 3 Americans blame doctors for national opioid epidemic, STAT-Harvard poll finds
Mar 16, 2016
Mar 15, 2016
-
MIT Technology Review
T-Cell Pioneer Carl June Acknowledges Key Ingredient Wasn’t His
-
Reuters
Indian court grants temporary relief to Abbott, Glenmark in drug ban case
-
The Street
Celator Pharma Surprises With Blood Cancer Drug Survival Benefit
-
Waste Dive
Massachusetts becomes first state to mandate drug take-back program
Mar 14, 2016
-
Kansas City Star
U.S. hospitals try strategies to counter rising drug prices
-
Wall Street Journal
Bristol-Myers Bucks Trend Toward Precision Medicine
-
STAT
Is do-it-yourself CRISPR as scary as it sounds?
Previous
